One-Year Efficacy and Safety of Rosuvastatin + Fenofibric Acid Combination Therapy in Patients with Mixed Dyslipidemia: Evaluation of Dose Response

By Ferdinand Keith C.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 117-125

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension: A Randomized, Double-Blind, Parallel-Group, Multicentre, Multinational, Phase III Study

By Fogari Roberto  

Clinical Drug Investigation, Vol. 30, Iss. 9, 2010-09 ,pp. : 581-597

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Rosuvastatin 5 mg in Combination with Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia – A Phase 3 Study

By Roth Eli   Rosenson Robert   Carlson Dawn   Fukumoto Sandra   Setze Carolyn   Blasetto James   Khurmi Nardev   Stolzenbach James   Williams Laura  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 421-428

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials

By Jones Peter H.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 73-84

Adis International

Access to resources Recommend Favorite

Safety of the Combination of Intensive Cholesterol-Lowering Therapy with Oral Anticoagulation Medication in Elderly Patients with Atrial Fibrillation: A Randomized, Double-Blind, Placebo-Controlled Study

By Enajat Morteza  

Drugs & Aging, Vol. 26, Iss. 7, 2009-07 ,pp. : 585-593

Adis International

Access to resources Recommend Favorite